Dr. Anok Singh Rana Answers: Why Did Miscarriage Happen Even After IVF?
Dr. Anok Singh Rana, Chief Operating Officer at Neelkanth ivf group, posted on LinkedIn:
“Why Can Miscarriage Still Happen After IVF?
An Honest Reality
IVF is an advanced medical science, but it is not a guarantee.
One of the most common and painful questions couples ask is:
‘Why did miscarriage happen even after IVF?’
The truth is, IVF reduces infertility challenges, but it does not completely eliminate the risk of miscarriage.
Average miscarriage risk after IVF:
- Around 10–20%,
- Varies based on age, embryo quality, and maternal health.
Common reasons for miscarriage after IVF:
- Embryo quality
Even after implantation, genetically abnormal embryos may not continue to develop. This remains the most common cause. - Age factor
After 35, egg quality declines, increasing the risk of chromosomal abnormalities. - Uterine factors
Fibroids, polyps, thin endometrium, or a mismatch in the implantation window can affect pregnancy continuation. - Hormonal imbalance
Low progesterone, thyroid disorders (T3/T4), uncontrolled diabetes, or PCOS can negatively impact early pregnancy. - Immunological and clotting disorders
Conditions like APS and thrombophilia can interfere with proper placental development. - Lifestyle and stress
Smoking, obesity, poor sleep, and chronic stress quietly reduce IVF success rates.
An important message for patients:
A miscarriage does not mean IVF has failed and it does not mean future pregnancy is impossible. Every miscarriage offers clinical insight to plan the next cycle in a more precise and personalized way.
From a clinician and healthcare leadership perspective:
Our responsibility is not only to achieve pregnancy,
but to ensure correct diagnosis, honest counseling, and emotional support.
IVF is science.
But a successful patient journey is built on trust, clarity, and care.”
Discover the latest in Hemostasis Today.
-
Jul 13, 2026, 17:21Stefano Navarro: Presenting Our Recently Published Article at ISTH 2026
-
Jul 13, 2026, 17:12Santagata Davide: A Great Session and an Incredible Opportunity to Present Our Research at ISTH 2026
-
Jul 13, 2026, 16:26Real-World Data Across Time Reveal Important Advances in Hemophilia Treatment – ATHN
-
Jul 13, 2026, 16:19Mary Cushman: Celebrating Our Incredible ISTH Council Members in Paris
-
Jul 13, 2026, 16:17Wolfgang Miesbach: Gene Therapy Shows Promising Early Results in Adolescents With Hemophilia B at ISTH 2026
-
Jul 13, 2026, 16:06Dino Mehic: Honored to Receive the ISTH Early Career Top Reviewer Awards
-
Jul 13, 2026, 16:01Advancing DIC Diagnosis in Cirrhosis Through Disease-Specific Risk Stratification – JTH
-
Jul 13, 2026, 15:52Joshua Muia: Presenting Our Research on ADAMTS13/VWF Dysregulation in Sepsis at ISTH 2026
-
Jul 13, 2026, 15:42Marc Carrier: Important New Data From the API-CAT Trial on Recurrent VTE During Extended Apixaban Therapy